FDA Inspection
Mirum Pharmaceuticals, Inc.Mirum Pharmaceuticals, Inc. – FDA Inspection, Jul 24, 2026
Record Details
This FDA Inspection record concerns Mirum Pharmaceuticals, Inc., with an inspection on July 24, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · e9d59fb4-c972-4887-b533-d10fdca95bc0
Inspection Facts
- Inspection number
- 1328024
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
FDA Citations
1- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mirum Pharmaceuticals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2024 | Not classified | San Francisco District Office | |
| October 3, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 12, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mirum Pharmaceuticals, Inc.
- FDA Inspection 1259153 - 2024-12-05
- FDA Inspection 1220683 - 2023-10-03
- FDA Inspection 1142794 - 2021-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.